Alkem Laboratories has informed that the Company is in compliance with the provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (Listing Regulations) and has been promptly intimating the Stock Exchanges regarding all events/ information which may have a bearing on the operation/ performance of the Company. There is no undisclosed price sensitive information which needs to be informed to the exchange at this point of time. Further, informed that Company will, as required under the Listing Regulations continue to promptly intimate the stock exchanges of all material events / information / actions.
The above information is a part of company’s filings submitted to BSE.
